Solventum SOLV MedSurg — Depreciation expense

Similar metrics at other companies

GATXDepreciation expense

$169.2M+63.3%

ADNTDepreciation expense

-$74M-4.2%

SRCEDepreciation expense

$423K-31.7%

CASHDepreciation expense

$7.55M-34.8%

SEIDepreciation expense

$26.37M+330%

JPMDepreciation expense

$698M+19.7%

FAQ

What is Solventum's medsurg — depreciation expense?

Solventum (SOLV) reported medsurg — depreciation expense of $32.75M in Q4 2025.

How has Solventum's medsurg — depreciation expense changed year-over-year?

Solventum's medsurg — depreciation expense increased by 6.5% year-over-year, from $30.75M to $32.75M.

What is the long-term trend for Solventum's medsurg — depreciation expense?

Over 3 years (2022 to 2025), Solventum's medsurg — depreciation expense has grown at a -3.1% compound annual growth rate (CAGR), from $144M to $131M.

What does medsurg — depreciation expense mean?

The systematic allocation of the cost of tangible assets, such as machinery and equipment, over their useful lives within the MedSurg segment. This non-cash expense reflects the wear and tear of the segment's physical capital base.